CanSino Biologics Financials
| CJH Stock | EUR 3.98 0.04 1.02% |
CanSino |
Understanding current and past CanSino Biologics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CanSino Biologics' financial statements are interrelated, with each one affecting the others. For example, an increase in CanSino Biologics' assets may result in an increase in income on the income statement.
CanSino Biologics Stock Summary
CanSino Biologics competes with JSC Halyk, Perseus Mining, CVS Health, Hanover Insurance, and ATRYS HEALTH. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the Peoples Republic of China. CANSINO BIOLOGICS operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 726 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | CNE100003F01 |
| Business Address | 401-420, Biomedical Park, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.cansinotech.com |
| Phone | 400 922 2099 |
| Currency | EUR - Euro |
You should never invest in CanSino Biologics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CanSino Stock, because this is throwing your money away. Analyzing the key information contained in CanSino Biologics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CanSino Biologics Key Financial Ratios
There are many critical financial ratios that CanSino Biologics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CanSino Biologics reports annually and quarterly.| Return On Equity | 0.0111 | |||
| Return On Asset | -0.0207 | |||
| Beta | 0.61 | |||
| Z Score | 46.8 |
CanSino Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CanSino Biologics's current stock value. Our valuation model uses many indicators to compare CanSino Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CanSino Biologics competition to find correlations between indicators driving CanSino Biologics's intrinsic value. More Info.CanSino Biologics is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CanSino Biologics' earnings, one of the primary drivers of an investment's value.CanSino Biologics Systematic Risk
CanSino Biologics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CanSino Biologics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on CanSino Biologics correlated with the market. If Beta is less than 0 CanSino Biologics generally moves in the opposite direction as compared to the market. If CanSino Biologics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CanSino Biologics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CanSino Biologics is generally in the same direction as the market. If Beta > 1 CanSino Biologics moves generally in the same direction as, but more than the movement of the benchmark.
CanSino Biologics December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CanSino Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CanSino Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of CanSino Biologics based on widely used predictive technical indicators. In general, we focus on analyzing CanSino Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CanSino Biologics's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.73 | |||
| Information Ratio | 0.1615 | |||
| Maximum Drawdown | 39.56 | |||
| Value At Risk | (6.64) | |||
| Potential Upside | 11.33 |
Complementary Tools for CanSino Stock analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |